Results 171 to 180 of about 162,494 (358)
ABSTRACT Objectives We prospectively investigated the risk of colonoscopy‐related bleeding in relation to antithrombotic treatment. Methods This prospective, observational, single‐center cohort study (NCT02594813) enrolled consecutive patients who underwent colonoscopy, including the removal of colorectal polyps, regardless of the continuation of ...
Emi Nonaka +5 more
wiley +1 more source
Abstract Secondary aortoduodenal fistula (sADF) is a rare but life‐threatening complication after aortic graft surgery. Diagnosis is often challenging, particularly when contrast‐enhanced computed tomography (CT) and endoscopy results are inconclusive. We report a case in which diagnosis was challenging due to contrast media allergy and non‐diagnostic ...
Jun Kubota +6 more
wiley +1 more source
Jin Ah Jung,1 Soo-Yun Lee,2 Tae-Eun Kim,3 Jung-Ryul Kim,1 Chin Kim,4 Wooseong Huh,1,5 Jae-Wook Ko1,2 1Department of Clinical Pharmacology and Therapeutics, Samsung Medical Center, 2Department of Health Sciences and Technology, Samsung Advanced Institute ...
Jung JA +6 more
doaj
ABSTRACT Aortoesophageal fistula (AEF) is a rare but life‐threatening condition. Initial management typically includes thoracic endovascular aortic repair (TEVAR) or aortic graft replacement to achieve hemostasis, followed by esophagectomy with aortic graft replacement and greater omentum wrapping to eliminate the source of infection.
Ryosuke Kawagoe +4 more
wiley +1 more source
Collaborative Study of a Semiautomated Method for the Analysis of Acenocoumarol, Phenprocoumon, and Potassium Warfarin Tablets [PDF]
Richard E. Kolinski
openalex +1 more source
ABSTRACT Background This study investigated the quality and clinical outcomes of the British Orthopaedic Foot and Ankle Society (BOFAS) registry first metatarsophalangeal joint (MTPJ) arthrodesis pathway. Methods A prospective cohort study using data derived from the BOFAS registry.
Ferozkhan Jadhakhan +4 more
wiley +1 more source
Surreptitious Warfarin Ingestion in three Nurses with Co-Existing Bleeding Disorders [PDF]
Ormille A. Hayne +3 more
openalex +1 more source
Drug-binding properties of rat α-foetoprotein. Specificities of the phenylbutazone-binding and warfarin-binding sites [PDF]
Françoise Hervé +4 more
openalex +1 more source
ABSTRACT Breakthrough hemolysis (BTH) is defined as a hemolytic exacerbation in a patient with paroxysmal nocturnal hemoglobinuria (PNH) treated with complement inhibitors (CIs). In the current era of several terminal and proximal inhibitors, there are no guidelines for defining BTH and its severity, and clinical management is not standardized.
Bruno Fattizzo +23 more
wiley +1 more source

